Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Effectiveness and Safety of Embella (Deoxycholic Acid, Produced by Espad Pharmed Co.) for the Management of Submental Fat

NCT06509438 is registered in ClinicalTrials.gov with Espad Pharmed as lead sponsor.

NCT NCT06509438
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06509438 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Effectiveness and Safety of Embella (Deoxycholic Acid, Produced by Espad Pharmed Co.) for the Management of Submental Fat
Lead sponsor
Espad Pharmed
Phase
Not applicable
Overall status
Completed
Start date
April 10, 2023
Completion date
January 1, 2024
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

submental fullness